$0.34
+1.7%Micromidas, Inc., doing business as Origin Materials, produces and commercializes plant-based PET plastic. It develops a platform for turning the carbon found in biomass into useful materials, while capturing carbon in the process. The company serves tire filler, carbon black, agriculture, and activated carbon markets. Micromidas, Inc. has a strategic alliance with Palantir Technologies Inc. The company was incorporated in 2008 and is based in West Sacramento, California with a facility in Sarnia, Canada.
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
ORGN • NASDAQ
| Origin Materials, Inc. Income Statement | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
REVENUE | ||||||
31.3M | 28.8M | 0.0 | 0.0 | 0.0 | 0.0 | |
GROSS PROFIT | ||||||
(30.9M) | (23.6M) | (0.0) | (0.0) | (0.0) | (0.0) | |
418K | 5.2M | 0.0 | 0.0 | 0.0 | 0.0 | |
OPERATING INCOME | ||||||
(85.3M) | (60.1M) | (38.9M) | (26.9M) | -11.2M | -11.1M | |
(40.8M) | (35.4M) | (24.1M) | (17.3M) | (6.6M) | (3.7M) | |
(18.6M) | (21.4M) | (14.1M) | (9.1M) | (4.1M) | (6.7M) | |
-84.9M | -54.9M | -38.9M | -26.9M | 11.2M | 11.1M | |
PRE-TAX INCOME | ||||||
(371K) | (131K) | (0.0) | (2.8M) | (341K) | (0.0) | |
-371K | 6.2M | 8.8M | -1.4M | 0.0 | 0.0 | |
(26M) | (3.4M) | (711K) | (544K) | -21.9M | (0.0) | |
1.8M | 77.6M | 117.5M | 69M | -41.5M | -11.5M | |
-83M | 22.7M | 78.6M | 42.1M | -30.3M | -479K | |
NET INCOME | ||||||
(669K) | -1.1M | (0.0) | (0.0) | (0.0) | (0.0) | |
-83.7M | 23.8M | 78.6M | 42.1M | -30.3M | -479K |
ORGN - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2025 N/A | December 11, 2025 | December 11, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 09, 2025 | November 25, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 17, 2025 | November 13, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 13, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 13, 2025 | November 13, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 08, 2025 | October 07, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 07, 2025 | October 07, 2025 | 2025 | |
S-3 S-3 N/A | August 14, 2025 | August 14, 2025 | ||
10-Q 10-Q 2025 Q2 Q2 | August 14, 2025 | June 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 14, 2025 | August 14, 2025 | 2025 |
Continue your ORGN research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.